You've worked hard to fund your portfolio — your investment strategy should work just as hard to maximize your after-tax returns. On August 20, join Range's CFPs and CPAs live for the practical moves that put more of your returns back in your pocket. 

What we'll cover:

 • Investment moves to maximize your after-tax returns

 • How tax-loss harvesting can lower the taxes you owe

 • When direct indexing works (and when it doesn't) 

• How to build a diversified portfolio that reduces tax drag. 

Range is all-in-one AI wealth management — tax, investments, retirement, and estate in one place. Bring your questions for the live Q&A. Free to attend, and seats are limited.

Reserve your spot today

_{This webinar is for informational purposes only and does not constitute investment advice or a recommendation to buy, hold, or sell any security. Forward-looking statements involve risks and uncertainties. Past performance is not indicative of future results. Range defines "high earners" as households with income over $300k.}

Every week, we cut through the noise and surface opportunities that institutions are already eyeing, but with strategies tailored for retail traders. Today's setup is a company trading at roughly 6.5 times forward earnings that spent two decades renting out its two best brands to somebody else. On December 31, it stops.

We’ll cover:

PVH owns Calvin Klein and Tommy Hilfiger. That is essentially the whole company, and the market values it at about $3.8 billion, or 0.42 times sales.

Here is the part almost nobody is tracking. For more than twenty years, PVH did not actually sell a large part of its own women's business. It licensed it to G-III Apparel Group and collected a royalty. PVH declined to renew long term in late 2022, and the wind-down runs through 2027. The next tranche is the one that matters: Calvin Klein and Tommy Hilfiger women's dresses and women's suits all expire on December 31, 2026, with no renewal terms.

The mechanism in one sentence: revenue that sits on a licensee's income statement, where PVH earns only a royalty, becomes PVH's own revenue at PVH's own margin. G-III's annual report puts the two brands at roughly 28% of its net sales, about $827 million, down from $1.5 billion in fiscal 2023, with a further $470 million decline expected before they roll off entirely.

So why is $PVH at 6.5 times forward earnings? Because revenue is guided flat while Europe is weak, because the two companies are suing each other over more than $250 million, and because JPMorgan cut the stock to Underweight on August 4. All three are real. None repeals the expiration date.

Behind the scenes:

📅 A dated catalyst, not a narrative: December 31 is written into a license agreement, not an analyst's model.

💰 The valuation is an artifact: the mid-20s trailing P/E reflects a $480 million non-cash impairment in fiscal 2025. On the $11.80 to $12.10 forward guide, the stock is near 6.5 times.

🐻 Positioning is washed out: 10.48% short float, with 3.09 puts open for every call.

🏛️ Hedgeye just bought it: added to Investing Ideas August 12 at the low end of its range, and it closed down 3.85% that same day. Two sessions later the stock is still within about 1% of that level.

The wind-down is a schedule, not a projection.

The business itself is steady rather than exciting: first quarter revenue of $2.03 billion, non-GAAP EPS of $2.01, and a reaffirmed 8.8% operating margin guide. Note that 8.8%. The bull case says the reclaimed categories consolidate at 15% to 20%, but PVH has not disclosed that and it sits well above the company's own guide, so we are not printing it as fact. The revenue mechanism is documented. The margin on it is the honest unknown here.

✅ Trading above the 50-day moving average near $80.10

✅ Trading above the 200-day moving average near $76.75

✅ Sitting below the 20-day moving average near $84.20, the air pocket the downgrade created

✅ Roughly 18% below the 52-week high of $100.75

The Setup: PVH is up about 23% year to date and gave back 5.8% last week on the downgrade. That pullback put price back on top of support instead of extended above it. Coiled rather than directional, which is what you want when you are paying for a dated catalyst.

Who should take this trade: patient value traders who can hold through an earnings print. The entry exists precisely because the chart is unresolved, so if you need confirmation first, this is not your setup.

Why a spread and not a long call. PVH 30-day implied volatility is 51.87% against historical volatility of 33.61%, about 18 points rich. Selling the upside wing gets you paid for that richness instead of paying it.

🟢 Trade Setup

🛡️ Options Play:

Why these strikes and this expiry. The $80 strike sits at the 50-day average and the institutional entry. The $100 strike is the 52-week high, so maximum payout needs only a round-trip to where PVH traded this year. We repriced the same spread across every listed month at Friday's close. December is thirty cents cheaper, but it expires thirteen days before the handover, which disqualifies it. March shows open interest of 0 contracts on the strike we would buy. The 2028 LEAP costs $12.50 and caps the return near 60%. January carries by far the deepest open interest on the board, 133 and 530 contracts, and clears the catalyst by fifteen days. One honest note: last week January was also the cheapest in raw dollars. It no longer is. It wins now on liquidity and on clearing the date, not on price.

📉 Risk-Reward Breakdown

💰 Payoff Table (one spread, at expiration)

How it works. You pay $920 up front and that is the entire risk, known the day you enter. Below $80 in January it is gone. Above $89.20 you are making money, and at $100 or better you collect the full $1,080. You give up everything above $100, the price of not overpaying for rich volatility. Your shares keep running regardless.

(Quotes 15-min delayed as of the August 14 close. Verify with live brokerage prices before entering.)

Use $76 as your hard risk line, just under the 200-day average. A decisive close below it says the base failed. Size so a move from $82.50 to $76 costs no more than 1% to 2% of your account, and treat the $920 debit as fully at risk. Earnings land inside this trade, which is why we used a defined-risk spread.

Keep your eyes on:

$PVH is not a story about apparel demand. It is a story about a contract. A company that owns two of the best-known brands in the world spent twenty years letting somebody else sell a chunk of them, and it is taking that business back on a published schedule. The most important piece lands December 31.

The market is not paying for that, because the two parties are suing each other and a large bank just cut the stock. But litigation is noise around a contract; it does not repeal an expiration date. What we like most is that the risk is knowable: a line at $76 on the shares, a maximum loss of $920 on the spread, and a catalyst with a date on it.

✅ Buy $PVH at $82.50 or better
💸 Buy the January 15, 2027 $80/$100 call spread for a $9.20 net debit

We'll be watching this one closely.

Want more trade ideas like this - plus weekly options plays and breakdowns?

👉 Join the Paid Resilient Trader Newsletter

For more in-depth trading strategies and market insights, upgrade to the paid version of our newsletter.

Our paid newsletter gives you:

Stay Liquid, my friends
- The Resilient Trader